CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Human Genetics

• Publication date

  2009-03-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajhg.2009.02.003PMID 19249009PMCID PMC2668007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allele‐specific silencing of mutant Huntington’s disease gene

  2009cited by this paper
• Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation

  2008cited by this paper
• Huntington's disease: genetic heterogeneity in black African patients.

  2008cited by this paper
• AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.

  2008cited by this paper
• CTCF cis-Regulates Trinucleotide Repeat Instability in an Epigenetic Manner: A Novel Basis for Mutational Hot Spot Determination

  2008cited by this paper
• Hijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease.

  2008cited by this paper
• Identification and Allele-Specific Silencing of the Mutant Huntingtin Allele in Huntington's Disease Patient-Derived Fibroblasts

  2008cited by this paper
• Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17

  2008cited by this paper
• Huntington's disease.

  2007cited by this paper
• A second generation human haplotype map of over 3.1 million SNPs

  2007cited by this paper
• A common SNP haplotype provides molecular proof of a founder effect of Huntington disease linking two South African populations

  2007cited by this paper
• Closely linked cis-acting modifier of expansion of the CGG repeat in high risk FMR1 haplotypes

  2007cited by this paper
• Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits

  2007cited by this paper
• OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells

  2007cited by this paper
• Late-onset and typical Huntington disease families from Crete have distinct genetic origins.

  2006cited by this paper
• Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models.

  2006cited by this paper
• An Evaluation of the Performance of Tag SNPs Derived from HapMap in a Caucasian Population

  2006cited by this paper
• rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse.

  2006cited by this paper
• The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation

  2006cited by this paper
• Predictive testing for Huntington disease: interpretation and significance of intermediate alleles

  2006cited by this paper
• Wild‐type huntingtin protects neurons from excitotoxicity

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• Ancient origin of the CAG expansion causing Huntington disease in a Spanish population

  2005cited by this paper
• Repeat instability: mechanisms of dynamic mutations

  2005cited by this paper
• Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.

  2005cited by this paper
• Silencing polyglutamine degeneration with RNAi.

  2005cited by this paper
• RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

  2005cited by this paper
• Transferability of Tag SNPs to Capture Common Genetic Variation in DNA Repair Genes Across Multiple Populations

  2005cited by this paper
• Effect of CAT or AGG Interruptions and CpG Methylation on Nucleosome Assembly upon Trinucleotide Repeats on Spinocerebellar Ataxia, Type 1 and Fragile X Syndrome*

  2005cited by this paper
• Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.

  2005cited by this paper
• Whole-Genome Patterns of Common DNA Variation in Three Human Populations

  2005cited by this paper
• Mosaicism of the CAG repeat sequence in the Huntington disease gene in a pair of monozygotic twins

  2004cited by this paper
• DNA Haplotype Analysis of CAG Repeat in Taiwanese Huntington’s Disease Patients

  2004cited by this paper
• MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment

  2004cited by this paper
• Genomic context drives SCA7 CAG repeat instability, while expressed SCA7 cDNAs are intergenerationally and somatically stable in transgenic mice.

  2003cited by this paper
• The contribution of cis-elements to disease-associated repeat instability: clinical and experimental evidence

  2003cited by this paper
• Molecular analysis of Huntington's disease and linked polymorphisms in the Indian population

  2003cited by this paper
• DNA stability and schizophrenia in twins

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.

  2002cited by this paper
• Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Δ2642 (E2642del) polymorphisms

  2002cited by this paper
• Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Loss of normal huntingtin function: new developments in Huntington's disease research.

  2001cited by this paper
• Linkage disequilibrium in the human genome

  2001cited by this paper
• High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia

  2001cited by this paper
• Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases.

  2001cited by this paper
• Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India

  2000cited by this paper
• Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium

  2000cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• Null Alleles at the Huntington Disease Locus: Implications for Diagnostics and CAG Repeat Instability

  2000cited by this paper
• Polymorphisms in the CAG repeat – a source of error in Huntington disease DNA testing

  2000cited by this paper
• Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice

  2000cited by this paper
• Triplet repeats form secondary structures that escape DNA repair in yeast.

  1999cited by this paper
• [Population genetic study of Huntington's disease--prevalence and founder's effect in the San-in area, western Japan].

  1999cited by this paper
• Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice

  1999cited by this paper
• A global haplotype analysis of the myotonic dystrophy locus: implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations.

  1998cited by this paper
• Huntington's disease confirmed by genetic testing in five african families

  1998cited by this paper
• Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability.

  1998cited by this paper
• Analysis of (CAG)n size heterogeneity in somatic and sperm cell DNA from intermediate and expanded Huntington disease gene carriers

  1997influential reference
• Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.

  1997cited by this paper
• Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene.

  1996cited by this paper
• Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.

  1996cited by this paper
• Inactivation of the mouse Huntington's disease gene homolog Hdh.

  1995cited by this paper
• Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.

  1995cited by this paper
• Haplotype analysis of the delta 2642 and (CAG)n polymorphisms in the Huntington's disease (HD) gene provides an explanation for an apparent 'founder' HD haplotype.

  1995cited by this paper
• Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

  1995cited by this paper
• Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.

  1995cited by this paper
• Origins and evolution of Huntington disease chromosomes.

  1995cited by this paper
• Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue

  1995cited by this paper
• The epidemiology of Huntington's disease in Northern Ireland.

  1995cited by this paper
• Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population.

  1995cited by this paper
• Convergent Myotonic Dystrophy (DM) Haplotypes: Potential Inconsistencies in Human Disease Gene Localization

  1995cited by this paper
• A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

  1994cited by this paper
• Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence

  1994cited by this paper
• Length of uninterrupted CGG repeats determines instability in the FMR1 gene

  1994cited by this paper
• Geographical distribution of haplotypes in Swedish families with Huntington's disease

  1994cited by this paper
• DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.

  1994cited by this paper
• High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.

  1994cited by this paper
• Huntington's disease in Hong Kong Chinese: epidemiology and clinical picture.

  1994cited by this paper
• Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis.

  1993cited by this paper
• DNA analysis of distinct populations suggests multiple origins for the mutation causing Huntington disease

  1993cited by this paper
• Origin of the expansion mutation in myotonic dystrophy

  1993cited by this paper
• Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

  1993cited by this paper
• Huntington's disease in Chinese: a hypothesis of its origin.

  1992cited by this paper
• Huntington disease in Maryland: clinical aspects of racial variation.

  1987cited by this paper
• Low prevalence of Huntington's disease in Finland.

  1987cited by this paper
• Huntington's disease

  1984cited by this paper
• Huntington’s Chorea

  1981cited by this paper
• The prevalence of Huntington's chorea in South Africa.

  1980cited by this paper
• LOW PREVALENCE OF HUNTINGTONS-DISEASE IN FINLAND

  year unknowncited by this paper

• Comprehensive picture of β-barrel transformation in the fibrillogenesis of odorant-binding proteins.

  2025cites this paper
• Allelic Diversity, De Novo CAG Expansions and Intergenerational Instability at the HTT Locus in a Sample from India

  2025cites this paper
• E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy

  2025cites this paper
• Dysregulation of miRNAs in Sicilian Patients with Huntington’s Disease

  2025cites this paper
• Durable HTT silencing using non-evolved dCas9 epigenome editors in patient-derived cells

  2025cites this paper
• Population-scale disease-associated tandem repeat analysis reveals locus and ancestry-specific insights.

  2025cites this paper
• Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research

  2025cites this paper
• Pharmacogenomics and CRISPR-based therapies.

  2025cites this paper
• Emerging Roles of Bile Acids in Neuroinflammation

  2025cites this paper
• Machado–Joseph disease in Brazil and other South American countries: A systematic Review and Meta-analysis of Prevalence, CAG Repeat Lengths, Age At Onset, and Ancestry

  2025cites this paper
• Allelic Diversity, de novo CAG Expansions, and Intergenerational Instability at the HTT Locus in a clinical sample of Huntingtons Disease from India

  2025cites this paper
• Variation in the reported prevalence of Huntington’s disease: a systematic review and guide to interpretation

  2025cites this paper
• The Epidemiology of Huntington’s Disease in Iceland

  2025cites this paper
• Nucleotide-Specific RNA Conformations and Dynamics as Precursors to Ribonucleoprotein Condensates.

  2025cites this paper
• Analysis of short tandem repeats linked to polyglutamine diseases from whole-genome sequencing reveals intermediate alleles of HTT associated with an early disease onset in C9orf72 carriers

  2025cites this paper
• Brain connectivity, neural networks, and resilience in aging and neurodegeneration.

  2025cites this paper
• Computational Framework for High Copy‐Number Probe Selection and Cross‐Binding Reduction

  2025cites this paper
• Investigation of Phytochemical and Antidepressants Activity of Cinnamon Powder Extract

  2024cites this paper
• Degradation of pathogenic amyloids induced by matrix metalloproteinase-9.

  2024cites this paper
• Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease

  2024cites this paper
• Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation

  2024cites this paper
• Latest advances on new promising molecular-based therapeutic approaches for Huntington’s disease

  2024cites this paper
• Genetics of Huntington’s disease and related disorders: beyond triplet repeats

  2024cites this paper
• Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases

  2024cites this paper
• Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases

  2024cites this paper
• Spinocerebellar ataxia type 2 has multiple ancestral origins

  2023cites this paper
• A model for the dynamics of expanded CAG repeat alleles: ATXN2 and ATXN3 as prototypes

  2023cites this paper
• Naïve Huntington’s disease microglia mount a normal response to inflammatory stimuli but display impaired development of innate immune tolerance that can be counteracted by ganglioside GM1

  2023cites this paper
• Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington’s disease

  2023cites this paper
• An in silico study to find potential effective circRNAs in the progression of Huntington’s disease

  2023cites this paper
• Amyloid Fibrils of Pisum sativum L. Vicilin Inhibit Pathological Aggregation of Mammalian Proteins

  2023cites this paper
• Conformational dynamics of RNA G4C2 and G2C4 repeat expansions causing ALS/FTD using NMR and molecular dynamics studies

  2023cites this paper
• Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders

  2023cites this paper
• Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route

  2023cites this paper
• Huntington disease-like 2: insight into neurodegeneration from an African disease

  2023cites this paper
• A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease

  2023cites this paper
• Naïve Huntington’s disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1

  2023cites this paper
• Global Epidemiology of Movement Disorders: Rare or Underdiagnosed?

  2023cites this paper
• Neurophysiological hallmarks of Huntington’s disease progression: an EEG and fMRI connectivity study

  2023cites this paper
• Conformational Dynamics of RNA G4C2 and C2G4 Repeat Expansions causing ALS/FTD using NMR and Molecular Dynamics Studies

  2023cites this paper
• Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing

  2022cites this paper
• PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease

  2022cites this paper
• Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington’s disease models

  2022cites this paper
• Spanish HTT gene study reveals haplotype and allelic diversity with possible implications for germline expansion dynamics in Huntington disease

  2022cites this paper
• Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in vivo in CNS

  2022cites this paper
• Non-surgical in vivo germ cell-mediated gene editing by CRISPR mutagenic chain reaction with the aid of magnetic nanoparticles.

  2022cites this paper
• Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population

  2022cites this paper
• Mitochondrial dynamics involves molecular and mechanical events in motility, fusion and fission

  2022cites this paper
• Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead.

  2022cites this paper
• Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic

  2022cites this paper
• Current and Possible Future Therapeutic Options for Huntington’s Disease

  2022cites this paper
• Structural Polymorphism of Lysozyme Amyloid Fibrils

  2022cites this paper
• Structural Polymorphism of Lysozyme Amyloid Fibrils

  2022cites this paper
• A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development

  2022cites this paper
• Disease Diagnosis based on Various Pattern Frequency from Extracted Exons

  2022cites this paper
• Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues

  2022cites this paper
• Distribution of Huntington’s disease Haplogroups in Indian population

  2021cites this paper
• Molecular Strategies to Target Protein Aggregation in Huntington’s Disease

  2021cites this paper
• Deletion and replacement of long genomic sequences using prime editing

  2021cites this paper
• Huntington’s Disease Pathogenesis: Two Sequential Components

  2021cites this paper
• Programming large target genomic deletion and concurrent insertion via a prime editing-based method: PEDAR

  2021cites this paper
• Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip

  2021cites this paper
• Is TGF-β1 a Biomarker of Huntington’s Disease Progression?

  2021cites this paper
• Haplogroups and the history of human evolution through mtDNA

  2020cites this paper
• Antisense oligonucleotide drugs for neurological and neuromuscular disease

  2020cites this paper
• Investigational Assay for Haplotype Phasing of the Huntingtin Gene

  2020cites this paper
• Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families

  2020cites this paper
• Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations

  2020cites this paper
• Mitochondrial biogenesis in organismal senescence and neurodegeneration.

  2020cites this paper
• Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East

  2020cites this paper
• Huntingtin gene CAG repeat size affects autism risk: Family-based and case-control association study.

  2020cites this paper
• Distribution of the HTT Gene A1 and A2 Haplotypes Worldwide: A Systematic Review

  2020cites this paper
• Development of Antisense Oligonucleotide Gapmers for the Treatment of Huntington's Disease.

  2020cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Dis-orders and Atherosclerosis: Pathophysiological Mecha-nisms and innovative Protocol Towards an Elegant New Era Of Health

  2020cites this paper
• Haplotype analysis encompassing HTT gene in Chinese patients with Huntington's disease

  2020influential citation
• Correlation Between CCG Polymorphisms and CAG Repeats During Germline Transmission in Chinese Patients with Huntington’s Disease

  2020cites this paper
• Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease

  2020cites this paper
• The Role of Mitochondrial DNA Individuality in the Pathogenesis of Parkinson’s Disease

  2020cites this paper
• C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

  2020cites this paper
• Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms

  2020cites this paper
• Quality Control in Huntington’s Disease: a Therapeutic Target

  2019cites this paper
• Apelin/APJ system: A novel promising target for neurodegenerative diseases

  2019cites this paper
• Full sequence of mutant huntingtin 3′-untranslated region and modulation of its gene regulatory activity by endogenous microRNA

  2019cites this paper
• Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease

  2019cites this paper
• Number and molecular brightness analysis reveals Htt25Q protein aggregation upon the uptake of Htt97Q aggregates.

  2019cites this paper
• Stress and Glucocorticoids as Experience-Dependent Modulators of Huntington's Disease

  2019cites this paper
• ATXN10 Microsatellite Distribution in a Peruvian Amerindian Population

  2019cites this paper
• Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases

  2019cites this paper
• Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

  2019cites this paper
• HTT haplogroups in Finnish patients with Huntington disease

  2019cites this paper
• HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.

  2019cites this paper
• Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases

  2019cites this paper
• Huntington disease: A quarter century of progress since the gene discovery.

  2019cites this paper
• Mutant Huntingtin Affects Diabetes and Alzheimer’s Markers in Human and Cell Models of Huntington’s Disease

  2019cites this paper
• Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington’s disease

  2019cites this paper
• Genetic risk factors for movement disorders in Finland

  2019cites this paper
• A Comprehensive Haplotype Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.

  2019cites this paper
• A Pipeline to Assess Disease-Associated Haplotypes in Repeat Expansion Disorders: The Example of MJD/SCA3 Locus

  2019cites this paper
• Glucagon-like peptide 1 (GLP-1)

  2019influential citation
• The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population

  2018cites this paper